Indicators on Clinical trial recruitment for ABBV-744 study You Should Know
In Phase A, members will obtain various doses and schedules of oral ABBV-744 pill to detect Harmless dosing routine. Further participants will probably be enrolled at the discovered monotherapy dosign routine. In Phase B, members will receive oral ruxolitinib and ABBV-744 will be specified as "include-on" therapy. In Phase C, individuals will acqui